Clinical Evaluation of a New Reduced Volume Bowel Preparation

NCT00321230 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2008-04-16

No results posted yet for this study

Summary

Monocentric, cleansing evaluation pilot study in patients undergoing colonoscopy.

Conditions

  • Colonoscopy

Interventions

DRUG

macrogol3350 NA sulphate NACL KCL ascorbic acid NA ascorbate

Sponsors & Collaborators

Principal Investigators

  • Alain Bitoun, MD · Hôpital Lariboisière

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-01-31
Completion
2001-05-31

Countries

  • France

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00321230 on ClinicalTrials.gov